{"id": "article-46834_0", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Continuing Education Activity", "content": "Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare primary cutaneous lymphoma that mimics panniculitis and is composed of cytotoxic alpha-beta T-cells. Distinction from the more aggressive primary cutaneous gamma delta T-cell lymphoma was made in the 2008 revision of the World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues. Autoimmune diseases occur in approximately 20 percent of cases, and lupus erythematosus panniculitis (LEP) is usually on the differential diagnosis due to its similar clinical and histologic features. This activity reviews how to properly evaluate for subcutaneous panniculitis-like T-cell lymphoma and further steps that should be taken when this disease is present. This activity highlights the role of the interprofessional team in caring for patients with this condition.", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Continuing Education Activity. Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare primary cutaneous lymphoma that mimics panniculitis and is composed of cytotoxic alpha-beta T-cells. Distinction from the more aggressive primary cutaneous gamma delta T-cell lymphoma was made in the 2008 revision of the World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues. Autoimmune diseases occur in approximately 20 percent of cases, and lupus erythematosus panniculitis (LEP) is usually on the differential diagnosis due to its similar clinical and histologic features. This activity reviews how to properly evaluate for subcutaneous panniculitis-like T-cell lymphoma and further steps that should be taken when this disease is present. This activity highlights the role of the interprofessional team in caring for patients with this condition."}
{"id": "article-46834_1", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Continuing Education Activity", "content": "Objectives: Review the presenting features of subcutaneous panniculitis-like T-cell lymphoma. Describe the evaluation of subcutaneous panniculitis-like T-cell lymphoma. Explain how to manage subcutaneous panniculitis-like T-cell lymphoma. Summarize the critical role of the interprofessional team in the detection, evaluation, and management of patients with subcutaneous panniculitis-like T-cell lymphoma. Access free multiple choice questions on this topic.", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Continuing Education Activity. Objectives: Review the presenting features of subcutaneous panniculitis-like T-cell lymphoma. Describe the evaluation of subcutaneous panniculitis-like T-cell lymphoma. Explain how to manage subcutaneous panniculitis-like T-cell lymphoma. Summarize the critical role of the interprofessional team in the detection, evaluation, and management of patients with subcutaneous panniculitis-like T-cell lymphoma. Access free multiple choice questions on this topic."}
{"id": "article-46834_2", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Introduction", "content": "Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare primary cutaneous lymphoma composed of cytotoxic alpha-beta T-cells that mimics panniculitis. [1] Distinction from the more aggressive primary cutaneous gamma delta T-cell lymphoma was made in the 2008 revision of the World Health Organization (WHO) Classification of Tumours of Hematopoietic and Lymphoid Tissues [1] . Autoimmune diseases occur in approximately 20% of cases, and lupus erythematosus panniculitis (LEP) is usually part of the differential diagnosis due to similar clinical and histologic features [2] .\u00a0 Histologically, the neoplastic CD8+, beta F1 expressing cytotoxic T-cells characteristically surround and disrupt individual adipocyte membranes (see Image. Subcutaneous Panniculitis). Most cases have a good prognosis and follow an indolent clinical course; however, 15% to 20% of cases are complicated by hemophagocytic syndrome (HPS) [2] [1] [3] [4] .", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Introduction. Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare primary cutaneous lymphoma composed of cytotoxic alpha-beta T-cells that mimics panniculitis. [1] Distinction from the more aggressive primary cutaneous gamma delta T-cell lymphoma was made in the 2008 revision of the World Health Organization (WHO) Classification of Tumours of Hematopoietic and Lymphoid Tissues [1] . Autoimmune diseases occur in approximately 20% of cases, and lupus erythematosus panniculitis (LEP) is usually part of the differential diagnosis due to similar clinical and histologic features [2] .\u00a0 Histologically, the neoplastic CD8+, beta F1 expressing cytotoxic T-cells characteristically surround and disrupt individual adipocyte membranes (see Image. Subcutaneous Panniculitis). Most cases have a good prognosis and follow an indolent clinical course; however, 15% to 20% of cases are complicated by hemophagocytic syndrome (HPS) [2] [1] [3] [4] ."}
{"id": "article-46834_3", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Etiology", "content": "SPTCL is connected with an autoimmune condition in approximately 20% of cases [5] . The incidence of SPTCL in patients with lupus erythematosus and of lupus erythematosus in patients with SPTCL is higher than that of the general population [4] .\u00a0Considering this association, some investigators have proposed the two entities exist on the same disease spectrum, and cases with overlapping features should be called atypical lymphocytic lobular panniculitis [6] [4] . Other explanations include a propensity for patients with one disease to develop the other or misdiagnosis [7] . Further studies need to be done to make any definitive conclusions.", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Etiology. SPTCL is connected with an autoimmune condition in approximately 20% of cases [5] . The incidence of SPTCL in patients with lupus erythematosus and of lupus erythematosus in patients with SPTCL is higher than that of the general population [4] .\u00a0Considering this association, some investigators have proposed the two entities exist on the same disease spectrum, and cases with overlapping features should be called atypical lymphocytic lobular panniculitis [6] [4] . Other explanations include a propensity for patients with one disease to develop the other or misdiagnosis [7] . Further studies need to be done to make any definitive conclusions."}
{"id": "article-46834_4", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Epidemiology", "content": "SPTCL accounts for less than 1% of non-Hodgkin lymphomas and has a slight bias for females.\u00a0 It occurs in both children and adults with an average age of onset of 36 years. [1] [2]", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Epidemiology. SPTCL accounts for less than 1% of non-Hodgkin lymphomas and has a slight bias for females.\u00a0 It occurs in both children and adults with an average age of onset of 36 years. [1] [2]"}
{"id": "article-46834_5", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Pathophysiology", "content": "Migration of the neoplastic T-cells to the adipocyte membrane is postulated to be facilitated by the expression of CCR5 on the neoplastic T-cells.\u00a0 The ligands for CCR5 (CCL3, CCL4, and CCL5) are located on the adipocyte membrane [3] .", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Pathophysiology. Migration of the neoplastic T-cells to the adipocyte membrane is postulated to be facilitated by the expression of CCR5 on the neoplastic T-cells.\u00a0 The ligands for CCR5 (CCL3, CCL4, and CCL5) are located on the adipocyte membrane [3] ."}
{"id": "article-46834_6", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Histopathology", "content": "There is a pattern of lobular panniculitis that typically spares the interlobular septa, epidermis, and dermis.\u00a0 A variably dense infiltrate consisting of lymphocytes(neoplastic T-cells and few reactive B-cells), and macrophages are present.\u00a0 The neoplastic T-cells are atypical with hyperchromatic nuclei and irregular nuclear membranes.\u00a0 By immunohistochemistry, these neoplastic T-cells express CD8, beta F1 and other cytotoxic T-cell markers including granzyme B, perforin, and TIA1.\u00a0 These CD8+ T-cells may be sparse but tend to surround or rim the adipocytes and distort the adipocyte membrane.\u00a0 The neoplastic T-cells directly adjacent to the adipocytes have a higher Ki67 proliferation index compared to LEP, which has a relatively lower Ki67 proliferation index.\u00a0 Karyorrhexis, mitoses, and fat necrosis are commonly seen [1] .\u00a0 Some cases have been documented to have mucin deposition, plasma cell aggregates, vacuolar interface changes, follicular plugging, epidermal atrophy, and periadnexal lymphocytes, making the distinction between SPTCL and LEP difficult at times [8] [6] [4] .", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Histopathology. There is a pattern of lobular panniculitis that typically spares the interlobular septa, epidermis, and dermis.\u00a0 A variably dense infiltrate consisting of lymphocytes(neoplastic T-cells and few reactive B-cells), and macrophages are present.\u00a0 The neoplastic T-cells are atypical with hyperchromatic nuclei and irregular nuclear membranes.\u00a0 By immunohistochemistry, these neoplastic T-cells express CD8, beta F1 and other cytotoxic T-cell markers including granzyme B, perforin, and TIA1.\u00a0 These CD8+ T-cells may be sparse but tend to surround or rim the adipocytes and distort the adipocyte membrane.\u00a0 The neoplastic T-cells directly adjacent to the adipocytes have a higher Ki67 proliferation index compared to LEP, which has a relatively lower Ki67 proliferation index.\u00a0 Karyorrhexis, mitoses, and fat necrosis are commonly seen [1] .\u00a0 Some cases have been documented to have mucin deposition, plasma cell aggregates, vacuolar interface changes, follicular plugging, epidermal atrophy, and periadnexal lymphocytes, making the distinction between SPTCL and LEP difficult at times [8] [6] [4] ."}
{"id": "article-46834_7", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- History and Physical", "content": "Patients present with multiple subcutaneous plaques and nodules typically on the lower extremities, upper extremities, or trunk [1] .\u00a0These lesions have overlying erythema, are usually painless, and range in size from 0.5-2.0 cm.\u00a0There may be lesions in different stages of healing, suggesting a waxing and waning clinical course [5] .\u00a0In contrast to primary cutaneous gamma delta T-cell lymphoma, ulceration is less common [3] .", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- History and Physical. Patients present with multiple subcutaneous plaques and nodules typically on the lower extremities, upper extremities, or trunk [1] .\u00a0These lesions have overlying erythema, are usually painless, and range in size from 0.5-2.0 cm.\u00a0There may be lesions in different stages of healing, suggesting a waxing and waning clinical course [5] .\u00a0In contrast to primary cutaneous gamma delta T-cell lymphoma, ulceration is less common [3] ."}
{"id": "article-46834_8", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- History and Physical", "content": "Systemic symptoms are present in about 50% of cases, including fever, chills weight loss, cytopenias, myalgias, and elevated liver function tests [1] .\u00a0These symptoms are seen more commonly in patients with concurrent HPS.\u00a0Lymph node and bone marrow involvement are not usually encountered [3] .", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- History and Physical. Systemic symptoms are present in about 50% of cases, including fever, chills weight loss, cytopenias, myalgias, and elevated liver function tests [1] .\u00a0These symptoms are seen more commonly in patients with concurrent HPS.\u00a0Lymph node and bone marrow involvement are not usually encountered [3] ."}
{"id": "article-46834_9", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Evaluation", "content": "The disease is usually confined to the subcutaneous tissue, but rare cases have disseminated to involve the lymph nodes, blood, and bone marrow.\u00a0 Laboratory testing reveals an elevated erythrocyte sedimentation rate or C-reactive protein.\u00a0Cytopenias, elevated liver function tests, and hepatosplenomegaly should prompt close monitoring for the development of HPS.\u00a0 18F-fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) may help assess the extent of disease upon presentation, response to treatment, and detection of\u00a0relapses [9] [5] .", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Evaluation. The disease is usually confined to the subcutaneous tissue, but rare cases have disseminated to involve the lymph nodes, blood, and bone marrow.\u00a0 Laboratory testing reveals an elevated erythrocyte sedimentation rate or C-reactive protein.\u00a0Cytopenias, elevated liver function tests, and hepatosplenomegaly should prompt close monitoring for the development of HPS.\u00a0 18F-fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) may help assess the extent of disease upon presentation, response to treatment, and detection of\u00a0relapses [9] [5] ."}
{"id": "article-46834_10", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Evaluation", "content": "A punch biopsy of the lesion should be submitted for pathologic evaluation, which will allow for assessment of the area of interest. No specific genetic profile has been identified, and the Epstein-Barr virus is usually not present.\u00a0Clonality of the neoplastic T-cells can be demonstrated by the identification of T-cell receptor rearrangements using polymerase chain reaction (PCR) or high throughput sequencing [3] .\u00a0However, clonality can also be observed in reactive lymphoid infiltrates and certain B-cell lymphomas, so results must be interpreted in the context of the clinical scenario [8] [6] . One study found monoclonal T-cell receptor gene rearrangements in 50% of cases [10] .", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Evaluation. A punch biopsy of the lesion should be submitted for pathologic evaluation, which will allow for assessment of the area of interest. No specific genetic profile has been identified, and the Epstein-Barr virus is usually not present.\u00a0Clonality of the neoplastic T-cells can be demonstrated by the identification of T-cell receptor rearrangements using polymerase chain reaction (PCR) or high throughput sequencing [3] .\u00a0However, clonality can also be observed in reactive lymphoid infiltrates and certain B-cell lymphomas, so results must be interpreted in the context of the clinical scenario [8] [6] . One study found monoclonal T-cell receptor gene rearrangements in 50% of cases [10] ."}
{"id": "article-46834_11", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Treatment / Management", "content": "Chemotherapy with one or multiple agents was the standard of care when SPTCL and primary cutaneous gamma delta T-cell lymphoma were thought to be the same disease.\u00a0 Disparities in prognosis prompted the distinction of these two entities in the 2008 revision of the WHO.\u00a0No standard treatment approach currently exists for SPTCL. Studies have shown that most cases are successfully treated with systemic corticosteroids or immunosuppressive agents such as etoposide, cyclosporine A, methotrexate, chlorambucil, and bexarotene [3] .", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Treatment / Management. Chemotherapy with one or multiple agents was the standard of care when SPTCL and primary cutaneous gamma delta T-cell lymphoma were thought to be the same disease.\u00a0 Disparities in prognosis prompted the distinction of these two entities in the 2008 revision of the WHO.\u00a0No standard treatment approach currently exists for SPTCL. Studies have shown that most cases are successfully treated with systemic corticosteroids or immunosuppressive agents such as etoposide, cyclosporine A, methotrexate, chlorambucil, and bexarotene [3] ."}
{"id": "article-46834_12", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Treatment / Management", "content": "Conventional doxorubicin-based chemotherapy may be employed when the disease is progressive [5] .\u00a0Radiation therapy can lead to long term remissions and may have a role in palliation in patients with localized disease.\u00a0Stem cell transplants can be performed in refractory or disseminated cases [1] [3] .\u00a0In patients with concurrent HPS, high dose corticosteroids with cyclosporine A or a stem cell transplant with chemotherapy are options [5] .", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Treatment / Management. Conventional doxorubicin-based chemotherapy may be employed when the disease is progressive [5] .\u00a0Radiation therapy can lead to long term remissions and may have a role in palliation in patients with localized disease.\u00a0Stem cell transplants can be performed in refractory or disseminated cases [1] [3] .\u00a0In patients with concurrent HPS, high dose corticosteroids with cyclosporine A or a stem cell transplant with chemotherapy are options [5] ."}
{"id": "article-46834_13", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Differential Diagnosis", "content": "Lupus erythematosus (LE) :", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Differential Diagnosis. Lupus erythematosus (LE) :"}
{"id": "article-46834_14", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Differential Diagnosis", "content": "Clinically, LE presents more commonly on the face and proximal extremities, while SPTCL usually shows on the lower extremities, upper extremities, and trunk.\u00a0Findings such as fever and hepatosplenomegaly may favor SPTCL. However, they can also sometimes be observed in LE.", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Differential Diagnosis. Clinically, LE presents more commonly on the face and proximal extremities, while SPTCL usually shows on the lower extremities, upper extremities, and trunk.\u00a0Findings such as fever and hepatosplenomegaly may favor SPTCL. However, they can also sometimes be observed in LE."}
{"id": "article-46834_15", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Differential Diagnosis", "content": "Histologically, LEP and SPTCL may display many of the same features, most notably involvement of the epidermis.\u00a0More often, LEP shows interface change, a mixture of CD4 and CD8 T-cells, lymphoid follicles or B-cell aggregates, aggregates of CD123+ plasmacytoid dendritic cells, plasma cell aggregates and intradermal mucin. A low Ki67 proliferation index in the T-cells rimming the adipocytes is another useful feature for distinguishing SPTCL from LEP, as is the lack of cytologically atypical T-cells [8] .\u00a0Inflammatory cells, such as eosinophils, neutrophils, and plasma cells, are more commonly observed in LE [3] .\u00a0A synthesis of the clinical features, histology, immunophenotyping, molecular analysis, and possibly repeat biopsies may be needed to differentiate the two entities.\u00a0Even so, some cases remain ambiguous [11] .", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Differential Diagnosis. Histologically, LEP and SPTCL may display many of the same features, most notably involvement of the epidermis.\u00a0More often, LEP shows interface change, a mixture of CD4 and CD8 T-cells, lymphoid follicles or B-cell aggregates, aggregates of CD123+ plasmacytoid dendritic cells, plasma cell aggregates and intradermal mucin. A low Ki67 proliferation index in the T-cells rimming the adipocytes is another useful feature for distinguishing SPTCL from LEP, as is the lack of cytologically atypical T-cells [8] .\u00a0Inflammatory cells, such as eosinophils, neutrophils, and plasma cells, are more commonly observed in LE [3] .\u00a0A synthesis of the clinical features, histology, immunophenotyping, molecular analysis, and possibly repeat biopsies may be needed to differentiate the two entities.\u00a0Even so, some cases remain ambiguous [11] ."}
{"id": "article-46834_16", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Differential Diagnosis -- Primary cutaneous gamma-delta T-cell lymphoma:", "content": "Primary cutaneous gamma delta T-cell lymphoma has a preference for middle-aged adults, and the lesions may be more superficial with surface ulceration [1] .\u00a0Systemic symptoms and lymphadenopathy are common, with HPS developing in 50% of cases. Histologically, three patterns can be observed: epidermotropic, dermal, and subcutaneous.\u00a0The subcutaneous pattern can appear similar to the lobular panniculitis seen in SPTCL. However, rimming of the adipocytes is less prominent. By immunohistochemistry, the neoplastic cells are positive for CD56, TCR gamma, TIA1, granzyme B, and perforin and are typically negative for CD4, CD8, and beta F1. Clonal rearrangements of the TRG and TRD genes are present.\u00a0This entity has a poor prognosis with a five-year survival of 10%. Extranodal natural killer/T-cell lymphoma, nasal type: May sometimes present with subcutaneous involvement.\u00a0 In contrast to SPTCL, this entity is positive for EBV [11] .", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Differential Diagnosis -- Primary cutaneous gamma-delta T-cell lymphoma:. Primary cutaneous gamma delta T-cell lymphoma has a preference for middle-aged adults, and the lesions may be more superficial with surface ulceration [1] .\u00a0Systemic symptoms and lymphadenopathy are common, with HPS developing in 50% of cases. Histologically, three patterns can be observed: epidermotropic, dermal, and subcutaneous.\u00a0The subcutaneous pattern can appear similar to the lobular panniculitis seen in SPTCL. However, rimming of the adipocytes is less prominent. By immunohistochemistry, the neoplastic cells are positive for CD56, TCR gamma, TIA1, granzyme B, and perforin and are typically negative for CD4, CD8, and beta F1. Clonal rearrangements of the TRG and TRD genes are present.\u00a0This entity has a poor prognosis with a five-year survival of 10%. Extranodal natural killer/T-cell lymphoma, nasal type: May sometimes present with subcutaneous involvement.\u00a0 In contrast to SPTCL, this entity is positive for EBV [11] ."}
{"id": "article-46834_17", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Prognosis", "content": "Most cases have an excellent prognosis and follow an indolent clinical course with a 5-year overall survival rate of 85% to 91% [6] [5] .\u00a0 HPS occurs in 15% to 20% of cases and portends a worse prognosis.\u00a0More recently, upper extremity involvement is connected with a worse prognosis [10] .", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Prognosis. Most cases have an excellent prognosis and follow an indolent clinical course with a 5-year overall survival rate of 85% to 91% [6] [5] .\u00a0 HPS occurs in 15% to 20% of cases and portends a worse prognosis.\u00a0More recently, upper extremity involvement is connected with a worse prognosis [10] ."}
{"id": "article-46834_18", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Complications", "content": "HPS complicates approximately 20% of cases and carries a 46% 5-year overall survival rate.\u00a0These patients will require more aggressive treatment [6] .", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Complications. HPS complicates approximately 20% of cases and carries a 46% 5-year overall survival rate.\u00a0These patients will require more aggressive treatment [6] ."}
{"id": "article-46834_19", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Deterrence and Patient Education", "content": "Subcutaneous panniculitis-like T-cell lymphoma is a well-behaving lymphoid neoplasm of the subcutaneous tissue that can\u00a0be often successfully treated with systemic corticosteroids or immunosuppressive agents [3] .", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Deterrence and Patient Education. Subcutaneous panniculitis-like T-cell lymphoma is a well-behaving lymphoid neoplasm of the subcutaneous tissue that can\u00a0be often successfully treated with systemic corticosteroids or immunosuppressive agents [3] ."}
{"id": "article-46834_20", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Pearls and Other Issues", "content": "Atypical lymphocytes rimming individual fat cells with apoptotic debris is characteristic of SPTCL. Neoplastic cells usually express\u00a0CD8, beta F1, granzyme B, perforin, and TIA1.\u00a0 CD56 and EBV are negative. Distinction from lupus panniculitis is difficult. TCR rearrangement studies may provide evidence for clonality. Final diagnosis often requires clinical correlation.", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Pearls and Other Issues. Atypical lymphocytes rimming individual fat cells with apoptotic debris is characteristic of SPTCL. Neoplastic cells usually express\u00a0CD8, beta F1, granzyme B, perforin, and TIA1.\u00a0 CD56 and EBV are negative. Distinction from lupus panniculitis is difficult. TCR rearrangement studies may provide evidence for clonality. Final diagnosis often requires clinical correlation."}
{"id": "article-46834_21", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Enhancing Healthcare Team Outcomes", "content": "An interprofessional team-best manages this disease.\u00a0 The primary care, nurse practioner, or emergency room physician is often the first to encounter these patients. Prompt referral to an oncologist/hematologist is recommended when lymphoma is suspected.\u00a0 These patients may present with subcutaneous lesions and sometimes\u00a0symptoms of HPS.\u00a0 A comprehensive patient evaluation, laboratory tests, and punch biopsy help clarify the diagnosis.\u00a0 Treatment most commonly includes immunosuppressive agents or systemic corticosteroids. The oncology nurse and pharmacist should educate the patient on the adverse effects of the chemotherapeutic agents and the duration of therapy. Continued monitoring of blood work is necessary. In addition, patients must be educated on aseptic techniques, hand washing, and avoid crowds during treatment.\u00a0 If HPS is present, treatment will be more aggressive. With an interprofessional team approach, the 5-year survival exceeds 80%.", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Enhancing Healthcare Team Outcomes. An interprofessional team-best manages this disease.\u00a0 The primary care, nurse practioner, or emergency room physician is often the first to encounter these patients. Prompt referral to an oncologist/hematologist is recommended when lymphoma is suspected.\u00a0 These patients may present with subcutaneous lesions and sometimes\u00a0symptoms of HPS.\u00a0 A comprehensive patient evaluation, laboratory tests, and punch biopsy help clarify the diagnosis.\u00a0 Treatment most commonly includes immunosuppressive agents or systemic corticosteroids. The oncology nurse and pharmacist should educate the patient on the adverse effects of the chemotherapeutic agents and the duration of therapy. Continued monitoring of blood work is necessary. In addition, patients must be educated on aseptic techniques, hand washing, and avoid crowds during treatment.\u00a0 If HPS is present, treatment will be more aggressive. With an interprofessional team approach, the 5-year survival exceeds 80%."}
{"id": "article-46834_22", "title": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Subcutaneous Panniculitis-Like T-cell Lymphoma -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}